Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Return on Capital Employed (2018 - 2019)

Historic Return on Capital Employed for Monopar Therapeutics (MNPR) over the last 2 years, with Q4 2019 value amounting to 0.51%.

  • Monopar Therapeutics' Return on Capital Employed fell 700.0% to 0.51% in Q4 2019 from the same period last year, while for Dec 2019 it was 0.51%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.45% for FY2019, which is 400.0% down from last year.
  • As of Q4 2019, Monopar Therapeutics' Return on Capital Employed stood at 0.51%, which was down 700.0% from 0.83% recorded in Q3 2019.
  • Monopar Therapeutics' 5-year Return on Capital Employed high stood at 0.38% for Q3 2018, and its period low was 2.03% during Q2 2018.